How should drug trading enterprises deal with drugs of questionable quality if they find them?

According to the provisions of the Measures for the Supervision and Administration of Drug Circulation (Provisional), if drug production and trading enterprises and medical institutions find fake and inferior drugs or drugs of doubtful quality in drug purchase and sales activities, they must report to the local drug regulatory department in a timely manner, and shall not sell or return or exchange the goods on their own. If the above-mentioned drugs are found during the import inspection, they shall be dealt with in accordance with the provisions of the Measures for the Administration of Imported Drugs.

Sales can be suspended and reported to the company's quality management.

The department conducts a review, and if the review is qualified, it can continue to sell; If it is unqualified after the re-examination, it must be handled according to the unqualified drug handling procedures. If the quality management department also finds its quality suspicious, it can ask a special drug inspection department to conduct a quality inspection.

Summary. Hello, first of all, the drugs with quality problems should be removed from the shelves and sealed in a timely manner, and the drugs that have been sold should be recalled in a timely manner, and resale should be prohibited, and at the same time, the number of drugs with quality problems should be cleaned up and verified.

Hello as good, first of all, the quality of the drug socks in a timely manner to remove and seal, the sold drugs in a timely recall, prohibit resale, at the same time shoot the vertical to clean up statistics, verify the number of drugs with quality problems.

Then report the drug quality situation to the local drug regulatory and administrative departments in a timely manner, and the market supervision is generally a false smile closed by the Administration, and at the same time, it is also necessary to report to the Ministry of Health Administration, and strive to minimize the harm and impact of drug quality problems.

The quality of drugs is related to the life and health of the general public, and drugs with quality problems should be dealt with in a timely manner to avoid a wider range of quality and safety accidents. So, what should be done with drugs that are found to have quality problems?

1. Remove and seal the drugs with quality problems in a timely manner, recall the drugs that have been sold in a timely manner, prohibit resale, and conduct cleaning statistics at the same time to verify the number of drugs with quality problems.

2. Contact the drug manufacturer in time to return and replace the goods, and suggest that the manufacturer track and recall the quality of the same batch of drugs to reduce the harm.

3. Report the drug quality to the local drug regulatory and administrative departments in a timely manner, generally the Market Supervision and Administration Bureau, and also report to the health administrative departments, and strive to minimize the harm and impact of the drug quality transportation problem.

Summary. Hello dear, if you find a drug of questionable quality during the sales process, here are some suggested ways to deal with it:1

Stop selling: Immediately stop selling suspicious drugs to ensure they don't continue to enter the market. This is to protect consumers from potential health risks.

2.Quarantine medications: Separate suspected medications from other medicines and label them for further processing.

This can help ensure that these medicines are not mistakenly re-put back into sale. 3.Contact the merchant or manufacturer:

If you are a retailer or distributor, contact the merchant or manufacturer immediately. Inform them of the quality issues you have found and provide the necessary information and evidence. They will ask you to return the medicine or take other measures.

4.Report to regulatory authorities: Notify local drug regulators and report the presence of suspected drugs to them.

They will be able to take appropriate steps to deal with the issue and possibly further investigation. 5.Evidence preserved:

Make sure to keep all evidence related to the suspected drug, such as lot number, packaging, invoices, etc. This information will help with further investigation and tracking. 6.

Notify consumers: If a suspicious drug has been sold to consumers, you need to notify them of potential quality issues as soon as possible and provide relevant advice, such as stopping use and consulting a doctor. Be transparent and ensure that consumer rights are protected.

Is it there? Hello dear, if you find a drug of questionable quality during the sales process, here are some suggested ways to deal with it:1

Stop selling: Immediately stop selling suspicious drugs to ensure they don't continue to enter the market. This is to protect consumers from potential health risks.

2.Quarantine medications: Separate suspected medications from other medicines and label them for further processing.

This can help ensure that these medicines are not mistakenly re-put back into sale. 3.Contact the merchant or manufacturer:

If you are a retailer or distributor, contact the merchant or manufacturer immediately. Inform them of the quality issues you have found and provide the necessary information and evidence. They will ask you to return the medicine or take other measures.

4.Report to regulatory authorities: Notify local drug regulators and report the presence of suspected drugs to them.

They will be able to take appropriate steps to deal with the issue and possibly further investigation. 5.Evidence preserved:

Make sure to keep all evidence related to the suspected drug, such as lot number, packaging, invoices, etc. This information will be useful for further investigation and tracking. 6.

Inform consumers: If a suspicious drug has been sold to consumers, you need to notify them as soon as possible of a potential quality problem and provide advice such as stopping use, consulting a doctor, etc. Be transparent and ensure that consumer rights are protected.

Pharmaceutical retail enterprises shall display drugs and abrasives with questionable quality during the inspection of the display of drugs

a.Withdraw the cabinet in time.

b.Stop selling.

c.Confirmed and processed by the quality management personnel.

d.Keep relevant records.

e.Approved by the General Manager.

Correct answer: ABCD

Answer] :d the drug manufacturer, operating enterprise, drug non-clinical safety evaluation research institute, and drug clinical trial institution fail to implement the "Good Manufacturing Practice for Drugs", "Good Management Practice for Drug Operation", "Good Management Practice for Non-clinical Drugs", and "Good Management Practice for Drug Clinical Trials" in accordance with the regulations, they will be given a warning and ordered to bring this correction within a time limit; if the correction is not made within the time limit, it shall be ordered to suspend production or business for rectification, and shall be fined not less than 5,000 yuan but not more than 20,000 yuan; If the circumstances are serious, the "Drug Production License", "Drug Business License" and the qualifications of drug clinical trial institutions shall be revoked. Therefore, the question D is selected.

Answer]: c. Supervision and sampling inspection is a targeted sampling inspection of drugs of doubtful quality found in the supervision and inspection of drugs found by the drug regulatory department in the drug supervision and management work in order to ensure the safety of the people's drug use. Random inspections are divided into national and provincial (autonomous regions and municipalities) levels.

The national drug sampling inspection is mainly based on evaluation and random inspection, and the provincial drug sampling inspection is mainly based on supervision and random inspection. The re-inspection refers to the inspection proposed to the drug inspection agency by the person who has been sampled to the drug inspection agency because of the objection to the test results of the drug inspection agency. Entrusting the section dismantling inspection refers to the fact that the enterprise entrusts an inspection agency with statutory inspection qualifications to conduct the inspection in order to supervise and judge the product quality of its raw jujube production and sales.

Answer: A

If a drug trading enterprise or user finds that there are potential safety hazards in the drugs it operates or uses, it shall immediately stop selling or using the drugs, notify the drug manufacturers or suppliers to complain, and report to the drug regulatory department. Drug dealers and users shall establish and keep complete records of late purchase and sale to ensure the traceability of drugs sold.